Santeer is described on its website as a CBD product brand under Prism Science. It offers CBD products for both humans and pets that are made with data-driven technology and the latest formulas on the market.
The brand recently announced in a press release that it does not add solubility enhancing chemicals to its products. Rather, it uses a patent-pending technology for optimal solubility. The brand has worked on developing over 300 formulations for optimal effects, consistency, and duration.
Chris Denicola collaborated with experts to help bring the latest science to the CBD market through Santeer. He shared his experience in the stress release, stating
“It seemed to me that the CBD industry needed to catch up with modern day technology. For example, I couldn’t understand why we were relying on antiquated products like tinctures that belong in a medieval apothecary, not in a world where you can order these products online and have them shipped to your doorstep.”
John Hogan, the Chief Commercial Officer of Santeer also stated,
“Using other methods of consumption would be like going back to a flip phone after using a smart phone,” He continued, “What consumers had before was working, but they simply didn’t know what they were missing.”
The brand has released on the market three variants of its chewable tablets for humans. These products include:
Dream promotes a restful sleep
Focus helps uses take on the day’s tasks
Each of these products contains the brand’s formulations and promotes the outcomes that users expect. To learn more about the brand and the products that it offers, users can visit the brand’s website today. The full press release concerning the announcement can be viewed here.